Soft Tissue Sarcomas of the Extremities: Surgical Margins Can Be Close as Long as the Resected Tumor Has No Ink on It.

BACKGROUND Soft tissue sarcomas (STS) arising in the extremities pose a therapeutic challenge due to concerns of functional morbidity. Resections with negative margins are the mainstay of therapy, but the prognostic significance of surgical margins remains controversial. The purpose of this study was to determine the prognostic impact of surgical margins and clear margin widths in patients with STS of the extremities. MATERIALS AND METHODS We assessed the relationship between local recurrence-free (LRFS), disease-specific (DSS), and metastasis-free survival (MFS) and potential prognostic factors retrospectively in a consecutive series of 643 patients treated at our institution between 1996 and 2016. Potential prognostic factors were assessed using univariate and multivariate analyses. RESULTS The median follow-up time after primary diagnosis was 5.4 years (95% confidence interval [CI]: 4.8-6.0). The five-year estimates of the DSS, LRFS, and MFS rates in the entire cohort were 85.3% (95% CI: 81.6-88.3), 65.3% (95% CI: 60.8-69.5) and 78.0% (95% CI: 74.1-81.4), respectively. Histological grade and the quality of surgical margins were independent prognostic factors of all three survival endpoints (LRFS, DSS, MFS) in multivariate analyses. Within the R0 subgroup, univariate and multivariate analyses of categorized (≤1 mm vs. 1-5 mm vs. >5 mm) and non-categorized margin widths revealed that close and wide negative margins led to similar outcomes. Adjuvant radiation improved local control independently, but not DSS and MFS. CONCLUSION Microscopically negative margins were associated with better LRFS, DSS, and MFS regardless of whether adjuvant radiation was applied. Here, surgical margins can be close as long as the resected tumor has no ink on it. IMPLICATIONS FOR PRACTICE In the present retrospective analysis of 643 patients with primary soft issue sarcomas of the extremities, surgical margins could be identified as independent predictors of local recurrence-free, disease-specific, and metastasis-free survival. Given the diminished outcome of patients left with positive margins, surgical efforts should aim to achieve microscopically negative margins whenever feasible. It is noteworthy that only the quality of surgical margins, but not the negative margin width attained, had an influence on the prognosis. Our findings suggest that surgical margins can be close as long as the resected tumor has no ink on it.

[1]  P Reichardt,et al.  Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  A. Haynes,et al.  The Width of the Surgical Margin Does Not Influence Outcomes in Extremity and Truncal Soft Tissue Sarcoma Treated With Radiotherapy. , 2016, The oncologist.

[3]  T. Filleron,et al.  Detection of local recurrences of limb soft-tissue sarcomas: Is magnetic resonance imaging (MRI) relevant? , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  L. Mariani,et al.  Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis. , 2016, The Lancet. Oncology.

[5]  R. Nout,et al.  High-grade soft tissue sarcomas of the extremities: surgical margins influence only local recurrence not overall survival , 2015, International Orthopaedics.

[6]  K. S. Hall,et al.  Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  T. Delaney,et al.  MRI surveillance following treatment of extremity soft tissue sarcoma , 2014, Journal of surgical oncology.

[8]  S. Steinberg,et al.  Efficacy of Adjuvant Radiation Therapy in the Treatment of Soft Tissue Sarcoma of the Extremity: 20-year Follow-Up of a Randomized Prospective Trial , 2014, Annals of Surgical Oncology.

[9]  A. Giuliano,et al.  Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. , 2014, International journal of radiation oncology, biology, physics.

[10]  A. Daigeler,et al.  Long-term outcome after local recurrence of soft tissue sarcoma: a retrospective analysis of factors predictive of survival in 135 patients with locally recurrent soft tissue sarcoma , 2014, British Journal of Cancer.

[11]  C. Fletcher The evolving classification of soft tissue tumours – an update based on the new 2013 WHO classification , 2014, Histopathology.

[12]  A. Stojadinovic,et al.  Impact of margin status and local recurrence on soft-tissue sarcoma outcomes. , 2013, The Journal of bone and joint surgery. American volume.

[13]  D. King,et al.  Extremity Soft Tissue Sarcoma Resections: How Wide Do You Need to Be? , 2012, Clinical orthopaedics and related research.

[14]  F. Sim,et al.  Do Surgical Margin and Local Recurrence Influence Survival in Soft Tissue Sarcomas? , 2010, Clinical orthopaedics and related research.

[15]  L. Mariani,et al.  Extremity Soft Tissue Sarcoma in a Series of Patients Treated at a Single Institution: Local Control Directly Impacts Survival , 2010, Annals of surgery.

[16]  J. Coindre Grading of soft tissue sarcomas: review and update. , 2009, Archives of pathology & laboratory medicine.

[17]  D. Citrin,et al.  The role of radiation therapy in the management of sarcomas. , 2008, The Surgical clinics of North America.

[18]  A. Rydholm,et al.  Increased risk of malignancies in a population-based study of 818 soft-tissue sarcoma patients , 2006, British Journal of Cancer.

[19]  T G Clark,et al.  Survival Analysis Part I: Basic concepts and first analyses , 2003, British Journal of Cancer.

[20]  M. Ballo,et al.  Prognostic factors for patients with localized soft‐tissue sarcoma treated with conservation surgery and radiation therapy , 2003, Cancer.

[21]  G. Rosen,et al.  High-Grade Extremity Soft Tissue Sarcomas: Factors Predictive of Local Recurrence and its Effect on Morbidity and Mortality , 2003, Annals of surgery.

[22]  Axel Hoos,et al.  Analysis of the Prognostic Significance of Microscopic Margins in 2,084 Localized Primary Adult Soft Tissue Sarcomas , 2002, Annals of surgery.

[23]  G. Demetri,et al.  Management of soft-tissue sarcomas: an overview and update. , 2000, The Lancet. Oncology.

[24]  C. Blomqvist,et al.  Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group Register. , 2000, European journal of cancer.

[25]  E. Casper,et al.  Multifactorial analysis of long-term follow-up (more than 5 years) of primary extremity sarcoma. , 1999, Archives of surgery.

[26]  M Schemper,et al.  A note on quantifying follow-up in studies of failure time. , 1996, Controlled clinical trials.

[27]  D H Leung,et al.  Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  J. Hendriks,et al.  Histologic multifocality of tis, T1–2 breast carcinomas implications for clinical trials of breast‐conserving surgery , 1985, Cancer.

[29]  P. Terrier,et al.  Primary Extremity Soft Tissue Sarcomas: Does Local Control Impact Survival? , 2016, Annals of Surgical Oncology.

[30]  A. Jemal,et al.  Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.

[31]  L. Mariani,et al.  Status of surgical margins and prognosis in adult soft tissue sarcomas of the extremities: a series of patients treated at a single institution. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.